Andre Larochelle
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andre Larochelle as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03206086 · Eltrombopag for Fanconi AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Fanconi Anemia · principal investigator
- N/ANCT00001529 · Improved Methods of Cell Selection for Bone Marrow Transplant AlternativesNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Graft-Versus-Host Disease, Graft-versus-leukemia, Donor Apheresis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Eltrombopag for the Treatment of Fanconi AnemiaZIAHL006205 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · fiscal years 2015 to 2025 · $1,079,663 awarded in 2025Same name and institution; not confirmed by an ID
- Gene Therapy for Inherited Blood DisordersZIAHL006172 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · fiscal years 2013 to 2025 · $1,439,551 awarded in 2025Same name and institution; not confirmed by an ID
- Generation of Hematopoietic Stem and Progenitor Cells from iPSCsZIAHL006217 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · fiscal years 2016 to 2025 · $1,079,663 awarded in 2025Same name and institution; not confirmed by an ID
- Hematopoietic Stem and Progenitor Cell ExpansionZIAHL006218 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · fiscal years 2016 to 2022 · $309,138 awarded in 2022Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:34 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.N Engl J Med · 2017462 citationsRCR 16.5
- Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag.Blood · 201990 citationsRCR 4.1
- Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates.Transfusion · 201626 citationsRCR 1.0
- Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones.Genes (Basel) · 202017 citationsRCR 0.6